Lao-Tzu Allan-Blitz, MD, MPH, discusses treatment strategies including resistance-guided therapy with molecular gyrA assays and the goal of potentially reintroducing ciprofloxacin as therapy for this infection.
Lao-Tzu Allan-Blitz, MD, MPH
Advertisement
Allan-Blitz is an assistant professor in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA.
Articles by Lao-Tzu Allan-Blitz, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Lenacapavir and the Future of HIV Prevention: PURPOSE Trials, Long-Acting PrEP, and What Comes Next
2
Initiatives Look to Strengthen Vaccine Policy and Governance in US
3
Hackensack Meridian Health Joins Phase 3 Trial of Pfizer’s Investigational C difficile Vaccine
4
Considering Diversified Treatment Strategies to Combat Gonorrhea Resistance
5